Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

1.
2.

Abuse-deterrent formulations, an evolving technology against the abuse and misuse of opioid analgesics.

Schaeffer T.

J Med Toxicol. 2012 Dec;8(4):400-7. doi: 10.1007/s13181-012-0270-y. Review.

PMID:
23073726
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine/naloxone in marginalized populations.

Stancliff S, Joseph H, Fong C, Furst T, Comer SD, Roux P.

J Addict Dis. 2012;31(3):278-87. doi: 10.1080/10550887.2012.694603.

PMID:
22873189
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations.

Turk DC, O'Connor AB, Dworkin RH, Chaudhry A, Katz NP, Adams EH, Brownstein JS, Comer SD, Dart R, Dasgupta N, Denisco RA, Klein M, Leiderman DB, Lubran R, Rappaport BA, Zacny JP, Ahdieh H, Burke LB, Cowan P, Jacobs P, Malamut R, Markman J, Michna E, Palmer P, Peirce-Sandner S, Potter JS, Raja SN, Rauschkolb C, Roland CL, Webster LR, Weiss RD, Wolf K.

Pain. 2012 Oct;153(10):1997-2008. doi: 10.1016/j.pain.2012.05.029. Epub 2012 Jul 5. Review.

PMID:
22770841
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Assessment and treatment of abuse risk in opioid prescribing for chronic pain.

Jamison RN, Serraillier J, Michna E.

Pain Res Treat. 2011;2011:941808. doi: 10.1155/2011/941808. Epub 2011 Oct 11.

PMID:
22110936
[PubMed]
Free PMC Article
6.

Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users.

Bazazi AR, Yokell M, Fu JJ, Rich JD, Zaller ND.

J Addict Med. 2011 Sep;5(3):175-80. doi: 10.1097/ADM.0b013e3182034e31.

PMID:
21844833
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Buprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence.

Fishman MJ, Wu LT, Woody GE.

Am J Psychiatry. 2011 Jul;168(7):675-9. doi: 10.1176/appi.ajp.2010.10060879. No abstract available.

PMID:
21724673
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review.

Yokell MA, Zaller ND, Green TC, Rich JD.

Curr Drug Abuse Rev. 2011 Mar;4(1):28-41. Review.

PMID:
21466501
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention.

Bachireddy C, Bazazi AR, Kavasery R, Govindasamy S, Kamarulzaman A, Altice FL.

Drug Alcohol Depend. 2011 Jul 1;116(1-3):151-7. doi: 10.1016/j.drugalcdep.2010.12.001. Epub 2011 Jan 12.

PMID:
21232882
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Interactions between buprenorphine and antiretrovirals: nucleos(t)ide reverse transcriptase inhibitors (NRTI) didanosine, lamivudine, and tenofovir.

Baker J, Rainey PM, Moody DE, Morse GD, Ma Q, McCance-Katz EF.

Am J Addict. 2010 Jan-Feb;19(1):17-29. doi: 10.1111/j.1521-0391.2009.00004.x.

PMID:
20132118
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk